about
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cellsThe genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR).Molecular mechanisms of diabetic vascular complicationsDifferential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cellsAntidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic ratsEpigenetic mechanisms in diabetic vascular complications.Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.MicroRNAs and diabetic complicationsApplication of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.Genetic Investigation of Complement Pathway Genes in Type 2 Diabetic Retinopathy: An Inflammatory PerspectiveInteractions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.MicroRNAs: potential mediators and biomarkers of diabetic complications.Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents.Lack of association between TLR4 genetic polymorphisms and diabetic nephropathy in a Chinese population.LOX-1 and ROS, inseparable factors in the process of endothelial damage.Relationship between glycosylated hemoglobin A1c and coronary flow reserve in patients with Type 2 diabetes mellitus.Cross-sectional correlations between the toe brachial index and lower limb complications in older people.The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.MicroRNA as Therapeutic Targets for Chronic Wound Healing.Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin.Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes.Ulva rigida improves carbohydrate metabolism, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.Inhibition of miR-25 aggravates diabetic peripheral neuropathy.Taxifolin attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?
P2860
Q26739691-711157E0-9370-44F1-8A30-B40E705E4F88Q28581615-5FD4DB11-EAA4-4496-8C68-1FB7BE221B18Q30433072-EA6B3D02-2D1E-4D1E-A1FE-BC9DF1D7EEBCQ33558421-0CC2910D-0734-48AB-A45F-4F80C827E17CQ33729972-04C7B1AC-C7E9-487D-AF76-3BCC5A2E0A71Q34469053-72DD22DA-1F39-4442-8894-C260E69D1CC5Q34986508-F3D41451-FA63-4F6B-90DA-75F8995FA1A4Q35947731-1493CE66-0C43-4117-9289-0AF1171F06FFQ36094855-36B408DF-5013-4C9D-A49A-84EBDA314686Q36374514-3DD9D7E0-8C46-40C4-AFDF-C7CB6B6BBC02Q36632944-3FEFFC6E-A3F6-4756-8D31-6E05110B0F1DQ36966063-26F94E85-9B29-462D-8C94-572987B0FF27Q37146727-F945F85E-A266-48F5-B04F-9EA04B9049F2Q37620374-EF9BD44B-0B7F-4CDE-8864-D09CBEE72074Q37693846-933773AD-2EDB-4B1D-B623-48806F12CC2CQ38216728-3866F98D-18FE-4B81-85EF-1E39D4290812Q38361356-C3B04DA8-98DA-4FEF-A490-46BBA7A8753BQ38932370-F86B4B68-1F2A-4CA2-AE9B-2516CD8E87B2Q40777113-C51DB747-BA56-4703-B137-8FBA4580B293Q41035554-E01006B5-E293-45A5-B8EA-AE9265C4B6C5Q41895967-F20CDCB4-87FC-4AA1-9A52-E80522F4B9A7Q43520470-2DA453C2-0D1B-4B27-A4D8-6EA6BC85B073Q46905338-44BFDDA8-E1C4-4EC1-9928-67601B5879F8Q47094741-4F1AE755-79B2-4E76-BC61-123B8C157736Q47731172-9098C2A7-AF18-4160-9CE4-4097C3F4E102Q50525708-9C3F7E63-DEF0-41D9-934E-C798D5AB7A99Q54976817-D5D455FE-BA9A-4D7B-B76A-4751D410DF1BQ55079098-7D7E7EA0-B0C0-4C9C-B659-37AA7BE4F261Q55397745-58916CF4-B564-411D-827A-0B64E859DDBE
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Microvascular complications of diabetes.
@ast
Microvascular complications of diabetes.
@en
type
label
Microvascular complications of diabetes.
@ast
Microvascular complications of diabetes.
@en
prefLabel
Microvascular complications of diabetes.
@ast
Microvascular complications of diabetes.
@en
P1476
Microvascular complications of diabetes.
@en
P2093
George L King
Zhiheng He
P304
215-38, xi-xii
P356
10.1016/J.ECL.2003.12.003
P577
2004-03-01T00:00:00Z